Advertisement
Screener

CHEMED CORPORATION (CHE) Material Contracts

CHEMED CORPORATION Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-04-13: Form 8-K; Exhibit 10.1; Description Sixth Amended and Restated Senior Secured Credit Facility by and among Chemed Corporation, JP Morgan Chase Bank, National Association and other lenders thereto as of April 3, 2026..
  • 2026-02-27: Form 10-K; Exhibit 10.29; Description Form of Stock Option Grant - 2025.
  • 2026-02-27: Form 10-K; Exhibit 10.20; Description Senior Executive Severance Policy as amended August 3, 2018.
  • 2026-02-27: Form 10-K; Exhibit 10.19; Description Change in Control Severance Plan as amended August 3, 2018.
FiledFormExhibitDescription
2026-04-138-K10.1Sixth Amended and Restated Senior Secured Credit Facility by and among Chemed Corporation, JP Morgan Chase Bank, National Association and other lenders thereto as of April 3, 2026.
2026-02-2710-K10.29Form of Stock Option Grant - 2025
2026-02-2710-K10.20Senior Executive Severance Policy as amended August 3, 2018
2026-02-2710-K10.19Change in Control Severance Plan as amended August 3, 2018
2025-07-3110-Q10.1Nicholas M. Westfall Transition and Separation Agreement
2024-02-018-K10.1David P. Williams Performance Share Units Grant Letter dated January 29, 2024
2023-02-2710-K10.29Form of Stock Option Grant - 2022
2022-06-298-K10.1Fifth Amended and Restated Senior Secured Credit Facility by and among Chemed Corporation, JP Morgan Chase Bank, National Association and other lenders thereto as of June 28, 2022.
2022-02-2810-K10.20Senior Executive Severance Policy as amended August 3, 2018
2022-02-2810-K10.19Change in Control Severance Plan as amended August 3, 2018
2020-02-2610-K10.29Form of Stock Option Grant - 2018
2019-02-2710-K10.20Senior Executive Severance
2019-02-2710-K10.19Change in Control Severance
2018-06-228-K10.1Fourth Amended and Restated Credit Agreement by and among Chemed Corporation, JP Morgan Chase Bank, National Association and other lenders thereto as of June 20, 2018, exhibits and schedules thereto.
2017-11-028-K10.2Corporate Integrity Agreement, effective October 30, 2017 between the Office of Inspector General of the Department of Health and Human Services and VITAS Hospice Services, L.L.C., VITAS Healthcare Corporation, VITAS Healthcare Corporation of California, VITAS Healthcare Corporation of Illinois, VITAS Healthcare Corporation of Florida, VITAS Healthcare Corporation of Ohio, VITAS Healthcare Corporation of Atlantic, VITAS Healthcare of Texas, L.P., VITAS Healthcare Corporation Midwest, and VITAS Healthcare Corporation of Georgia.
2017-11-028-K10.1Settlement Agreement, effective October 30, 2017 by and among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services, VITAS Hospice Services, L.L.C., VITAS Healthcare Corporation, VITAS Healthcare Corporation of California, VITAS Healthcare Corporation of Illinois, VITAS Healthcare Corporation of Florida, VITAS Healthcare Corporation of Ohio, VITAS Healthcare Corporation of Atlantic, VITAS Healthcare of Texas, L.P., VITAS Healthcare Corporation Midwest, VITAS Healthcare Corporation of Georgia, Chemed Corporation, and the various Relators named therein.
2016-06-098-K10.1Consulting Agreement of June 16, 2016 between Timothy S. O’Toole and Chemed Corporation
2016-02-2610-K10Chemed Corporation
2014-07-028-K10.1Third Amended and Restated Credit Agreement by and among Chemed Corporation, JP Morgan Chase Bank, National Association and other lenders thereto as of June 30, 2014, exhibits and schedules thereto.
2014-02-2710-K10.35Form of Stock Option Grant - 2013
2014-02-2710-K10.32Form of Performance Based Restricted
2013-01-228-K10.1Second Amended and Restated Credit Agreement by and among Chemed Corporation, JP Morgan Chase Bank, National Association and other lenders thereto as of January 18, 2013, exhibits and schedules thereto.
2011-04-2910-Q10.1Amended and Restated Credit Agreement - $350,000,000 Revolving Credit Facility, originally dated May 2, 2007, by and among JP Morgan Chase Bank, N.A. and Chemed Corporation as of March 1, 2011, exhibits and schedules thereto.
2011-02-2810-K10.35AEX-10.35A
2011-02-2810-K10.35BEX-10.35B
2009-10-3010-Q10.5Chemed Corporation Change In Control Severance Plan As Amended July 9, 2009.
2009-10-3010-Q10.4Chemed Corporation Senior Executive Severance Policy As Amended July 9, 2009.
2009-10-3010-Q10.3First Amendment to Employment Agreement dated July 9, 2009 - Timothy S. O'Toole.
2009-10-3010-Q10.2First Amendment to Employment Agreement dated July 9, 2009 - David P. Williams.
2009-10-3010-Q10.1First Amendment to Employment Agreement dated July 9, 2009 - Kevin J. McNamara.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Option Care Health, Inc. (OPCH)United States$3.602B20.52
Aveanna Healthcare Holdings, Inc. (AVAH)United States$2.703B7.22
Addus HomeCare Corp (ADUS)United States$2.129B17.80
BrightSpring Health Services, Inc. (BTSG)United States$11.078B37.65
AdaptHealth Corp. (AHCO)United States$0.759B-6.22